Measurement of Cancer Cell Growth Heterogeneity through Lentiviral Barcoding Identifies Clonal Dominance as a Characteristic of In Vivo Tumor Engraftment

• Olivier Nolan-Stevaux ,

  Contributed equally to this work with: Olivier Nolan-Stevaux, Donato Tedesco

  * E-mail: oliviern@amgen.com (ONS); dtedesco@cellecta.com (DT)

  Affiliation Oncology Research, Amgen, South San Francisco, California, United States of America

  ⨯
• Donato Tedesco ,

  Contributed equally to this work with: Olivier Nolan-Stevaux, Donato Tedesco

  * E-mail: oliviern@amgen.com (ONS); dtedesco@cellecta.com (DT)

  Affiliation Cellecta Inc., Mountain View, California, United States of America

  ⨯
• Seamus Ragan,

  Affiliation Genome Analysis Unit, Amgen, South San Francisco, California, United States of America

  ⨯
• Mikhail Makhanov,

  Affiliation Cellecta Inc., Mountain View, California, United States of America

  ⨯
• Alex Chenchik,

  Affiliation Cellecta Inc., Mountain View, California, United States of America

  ⨯
• Astrid Ruefli-Brasse,

  Affiliation Oncology Research, Amgen, South San Francisco, California, United States of America

  ⨯
• Kim Quon,

  Affiliation Therapeutic Innovation Unit, Amgen, Seattle, Washington, United States of America

  ⨯
• Paul D. Kassner

  Affiliation Genome Analysis Unit, Amgen, South San Francisco, California, United States of America

  ⨯